By Shannon Pettypiece Feb. 8 (Bloomberg) — A 27-year-old hay fever treatment being studied by Pfizer Inc. and Medivation Inc.
More here:
Pfizer, Medivation Drug May Help Huntington’s Disease Patients
By Shannon Pettypiece Feb. 8 (Bloomberg) — A 27-year-old hay fever treatment being studied by Pfizer Inc. and Medivation Inc.
More here:
Pfizer, Medivation Drug May Help Huntington’s Disease Patients